Brophebarbital

Brophebarbital
Clinical data
Other names	Brophebarbital
ATC code	none;
Legal status
Legal status	CA: Schedule IV;
Identifiers
	IUPAC name 5-Ethyl-5-(3-bromophenyl)-1,3-diazinane-2,4,6-trione;
CAS Number	3865-10-9 ;
ChemSpider	27289066 ;
UNII	LAD0UT1E4E;
CompTox Dashboard (EPA)	DTXSID50726647 ;
Chemical and physical data
Formula	C12H11BrN2O3
Molar mass	311.135 g·mol−1
3D model (JSmol)	Interactive image;
	SMILES Brc2cccc(c2)C1(CC)C(=O)NC(=O)NC1=O;
	InChI InChI=1S/C12H11BrN2O3/c1-2-12(7-4-3-5-8(13)6-7)9(16)14-11(18)15-10(12)17/h3-6H,2H2,1H3,(H2,14,15,16,17,18) ; Key:DFTKCGKSDZVCTO-UHFFFAOYSA-N ;
	(what is this?) (verify)

Brophebarbital is a barbiturate derivative. It has sedative and hypnotic effects and is considered to have a moderate abuse potential.^[1]

References

^ Eddy NB, Halbach H, Isbell H, Seevers MH (1965). "Drug dependence: its significance and characteristics". Bulletin of the World Health Organization. 32 (5): 721–33. PMC 2555251. PMID 5294186.

This sedative-related article is a stub. You can help Wikipedia by expanding it.